Glenmark Pharma gets USFDA nod to market drug for relapsing multiple sclerosis

Glenmark Pharma gets USFDA nod to market drug for relapsing multiple sclerosis The approved product is a generic version of Biogen Inc’s Tecfidera delayed-release capsules.

No comments:

Post a Comment